Cohen Yuval

Chief Executive Officer

1 company

Strong

Trades Analyzed

12M Win Rate

71.4%

Avg 3M Return

-3.0%

Avg 12M Return

+25.3%

Cohen Yuval is a Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.

Estimated insider holdings value: $2.2M based on current market prices.

Holdings by Company

CRBPJan 14, 2026

Current Shares188.2K

Value$2.25M

Net Activity-42,825

Bought: 55.3KSold: 98.1K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
May 13, 2019	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	995	$6.99	$6,954.85	+1.6%
Mar 14, 2019	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,530	$6.49	$9,929.70	+2.5%
May 15, 2018	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,725	$5.85	$10,091.25	+2.9%
Mar 14, 2018	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,160	$6.89	$7,986.60	+2.0%
Nov 10, 2017	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,000	$7.17	$7,168.50	+1.7%
Aug 11, 2017	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,695	$6.00	$10,170.00	+3.0%
May 11, 2017	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	3,250	$6.01	$19,539.00	+6.2%
Nov 22, 2016	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,340	$7.64	$10,237.60	+11.7%
Jun 6, 2016	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	1,500	$3.34	$5,010.00	+15.0%
May 18, 2016	CRBP Corbus Pharmaceuticals Holdings, Inc.	Chief Executive Officer	Buy	2,125	$2.40	$5,100.00	+27.0%